We are live on
!
Find out more
RC
RegentAtlantic Capital Portfolio holdings
AUM
$3.34B
1-Year Est. Return
14.54%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
–
AUM
$1.3B
AUM Growth
+$145M
(+12%)
Cap. Flow
+$68.7M
Cap. Flow
% of AUM
5.26%
Top 10 Holdings %
Top 10 Hldgs %
20.31%
Holding
446
New
42
Increased
173
Reduced
178
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Micro-Cap ETF
IWC
|
+$14.1M |
| 2 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$13.8M |
| 3 |
DXC Technology
DXC
|
+$9.37M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$9.1M |
| 5 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$6.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.94M |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.73M |
| 3 |
PG&E
PCG
|
+$1.62M |
| 4 |
Citigroup
C
|
+$1.48M |
| 5 |
AT&T
T
|
+$1.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.33% |
| 2 | Financials | 15.47% |
| 3 | Healthcare | 14.76% |
| 4 | Industrials | 8.89% |
| 5 | Consumer Discretionary | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.79T
| $47.1M | 3.61% |
834,184
-9,656
| -1% | -$503K |
|
|
AMJ
2
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $41.7M | 3.19% |
1,517,598
+6,376
| +0.4% | +$178K |
|
3
Berkshire Hathaway Class B
BRK.B
$1.06T
| $28.6M | 2.19% |
133,362
+1,333
| +1% | +$274K |
|
4
Johnson & Johnson
JNJ
$615B
| $23.4M | 1.79% |
169,076
-1,254
| -0.7% | -$167K |
|
5
Intel
INTC
$516B
| $22.8M | 1.75% |
481,618
+3,765
| +0.8% | +$183K |
|
6
Microsoft
MSFT
$2.9T
| $21.6M | 1.66% |
188,953
+6,740
| +4% | +$731K |
|
7
Pfizer
PFE
$141B
| $20.2M | 1.55% |
483,519
+12,692
| +3% | +$489K |
|
|
8
DXC Technology
DXC
$1.53B
| $20.2M | 1.55% |
215,770
+105,858
| +96% | +$9.37M |
|
9
Comcast
CMCSA
$84B
| $19.8M | 1.52% |
558,988
-2,439
| -0.4% | -$86.3K |
|
10
Elevance Health
ELV
$84.4B
| $19.7M | 1.51% |
72,051
-1,470
| -2% | -$382K |
|
11
Exelon
EXC
$47.8B
| $18.3M | 1.4% |
586,583
+26,574
| +5% | +$818K |
|
|
AET
12
DELISTED
Aetna Inc
AET
| $17M | 1.3% |
83,602
-3,502
| -4% | -$684K |
|
13
UnitedHealth
UNH
$392B
| $16.5M | 1.27% |
62,170
-2,632
| -4% | -$685K |
|
14
Northrop Grumman
NOC
$74.6B
| $15.9M | 1.22% |
50,056
-91
| -0.2% | -$27.7K |
|
|
CA
15
DELISTED
CA, Inc.
CA
| $14.8M | 1.14% |
335,953
-5,378
| -2% | -$232K |
|
16
Bank of America
BAC
$432B
| $14.5M | 1.11% |
493,072
+4,030
| +0.8% | +$123K |
|
|
17
Schwab Fundamental US Large Company Index ETF
FNDX
$26.5B
| $14.1M | 1.08% |
+1,064,160
| New | +$13.8M |
|
|
18
iShares Micro-Cap ETF
IWC
$1.45B
| $14M | 1.08% |
+131,904
| New | +$14.1M |
|
19
Valero Energy
VLO
$92.3B
| $13.9M | 1.07% |
122,572
-479
| -0.4% | -$54.4K |
|
20
Thermo Fisher Scientific
TMO
$196B
| $13.5M | 1.04% |
55,445
-1,082
| -2% | -$249K |
|
21
Walt Disney
DIS
$166B
| $13.3M | 1.02% |
113,322
+134
| +0.1% | +$14.9K |
|
22
Allstate
ALL
$64.8B
| $13M | 1% |
131,916
+485
| +0.4% | +$47.3K |
|
23
CVS Health
CVS
$138B
| $13M | 0.99% |
164,587
+1,999
| +1% | +$143K |
|
|
24
AT&T
T
$160B
| $12.6M | 0.96% |
495,299
-53,565
| -10% | -$1.31M |
|
25
iShares Core MSCI Emerging Markets ETF
IEMG
$153B
| $12.4M | 0.95% |
238,604
+378
| +0.2% | +$19.7K |
|
Similar funds
5L
W
MA
APA
MIAN
CCM
AC
DY
RegentAtlantic Capital's Q3 2018 Portfolio in Review
As of Q3 2018, RegentAtlantic Capital held 446 positions worth $1.3B, up 12% from $1.16B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
RegentAtlantic Capital deployed $68.7M of net new capital in Q3 2018, opening 42 new positions and adding to 173 existing holdings. Its largest new stake was iShares Micro-Cap ETF: 131,904 shares worth $14M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $1.94M trimmed.
- RegentAtlantic Capital's largest Q3 2018 buy was iShares Micro-Cap ETF: 131,904 shares worth $14M.
- RegentAtlantic Capital added most to DXC Technology in Q3 2018, an estimated $9.37M increase.
- RegentAtlantic Capital's biggest Q3 2018 reduction was Amgen, cutting an estimated $1.94M.
- RegentAtlantic Capital fully exited Andeavor in Q3 2018, selling an estimated $1.73M.
- RegentAtlantic Capital's ten largest holdings make up 20% of its $1.3B portfolio in Q3 2018.
- RegentAtlantic Capital opened 42 new positions and closed 14 in Q3 2018.
- RegentAtlantic Capital's portfolio value rose 12% quarter-over-quarter to $1.3B.
Based on RegentAtlantic Capital's 13F filing for Q3 2018, filed 30 Oct 2018.